News > Covid-19 drug Favipiravir safe, effective, says Glenmark
Covid-19 drug Favipiravir safe, effective, says Glenmark
LiveMint | 16/09/2021 09:04 AM | Click to read full article
Pharmaceutical major Glenmark has concluded post-marketing surveillance (PMS) study on Favipiravir, the company said in a BSE filing. Favipiravir was used to treat patients with moderate to mild Covid-19.
The study analysed a total of 1,803 in July 2020 to evaluate the safety and efficacy of Favipiravir in mild to moderate coronavirus patients.
